Memory configuration of a composite memory device
    31.
    发明授权
    Memory configuration of a composite memory device 有权
    复合存储设备的内存配置

    公开(公告)号:US07672172B2

    公开(公告)日:2010-03-02

    申请号:US12333674

    申请日:2008-12-12

    IPC分类号: G11C16/04

    CPC分类号: G11C16/16

    摘要: The present invention is related to a composite flash memory device comprises a plural sector flash memory array which is divided to plural sector that is a minimum erasing unit of the flash memory device, a flash memory array storing control commands which control a total system of the composite flash memory device and/or the only composite flash memory device in and sharing I/O line of the plural sector flash memory array, the read operation of the flash memory array is enable when the plural sector flash memory array is gained access.

    摘要翻译: 本发明涉及一种复合闪速存储装置,它包括被分成多个扇区的多扇区快闪存储器阵列,该多个扇区闪速存储器阵列是闪速存储器件的最小擦除单元,存储控制命令的闪存阵列, 复合闪速存储器件和/或唯一的复合闪速存储器件,并且共享多扇区快闪存储器阵列的I / O线,当获得多个扇区闪速存储器阵列时,闪存阵列的读取操作成立。

    Method For Detecting Prognosis Of Cancer
    34.
    发明申请
    Method For Detecting Prognosis Of Cancer 审中-公开
    检测癌症预后的方法

    公开(公告)号:US20070275420A1

    公开(公告)日:2007-11-29

    申请号:US10549811

    申请日:2004-03-19

    IPC分类号: G01N33/574 C07K16/40

    摘要: It is to provide a method and a kit for detecting the prognosis of cancer at high accuracy in a simple and rapid manner at low cost. The method is specifically a method for detecting the prognosis of cancer, at least including a step of detecting core-2 β 1,6-acetylglucosaminyltransferase in a sample collected from a biological organism to examine the relationship between the results of the detection and the prognosis of cancer in the biological organism, wherein core-2 β1,6-acetylglucosaminyltransferase is preferably core-2 β1,6-acetylglucosaminyltransferase-I; the biological organism is preferably human body; and the sample is preferably a living tissue.

    摘要翻译: 它以低成本提供以高精度以简单快速的方式检测癌症的预后的方法和试剂盒。 该方法特别是用于检测癌症预后的方法,至少包括在从生物有机体收集的样品中检测核-2β1,6-乙酰葡糖胺基转移酶的步骤,以检查检测结果与预后之间的关系 其中核-2β1,6-乙酰葡糖胺基转移酶优选为核-2β1,6-乙酰葡糖胺基转移酶-I; 生物体优选为人体; 样品优选为活组织。

    Crystal oscillator
    36.
    发明授权
    Crystal oscillator 失效
    水晶振荡器

    公开(公告)号:US07088032B2

    公开(公告)日:2006-08-08

    申请号:US11154289

    申请日:2005-06-16

    IPC分类号: H01L41/08

    摘要: A crystal oscillator of the present invention includes: a substrate provided in a package; a heating device arranged as surrounding an internal area of the substrate on at least one of the surfaces of the substrate; a crystal resonator or a crystal element and an oscillation circuit unit provided in an area enclosed by the heating device; a thermosensitive element which detects a temperature in an area enclosed by the heating device; and a control unit for controlling a heating value applied to the heating device based on a detection result of the thermosensitive element.

    摘要翻译: 本发明的晶体振荡器包括:设置在封装中的衬底; 加热装置,其布置成在所述基板的至少一个表面上包围所述基板的内部区域; 设置在由加热装置封闭的区域中的晶体谐振器或晶体元件和振荡电路单元; 热敏元件,其检测由所述加热装置包围的区域中的温度; 以及控制单元,用于基于热敏元件的检测结果控制施加到加热装置的加热值。

    Leukosialin: Ig fusion proteins
    39.
    发明授权
    Leukosialin: Ig fusion proteins 失效
    白细胞介素:Ig融合蛋白

    公开(公告)号:US06537553B1

    公开(公告)日:2003-03-25

    申请号:US08369754

    申请日:1995-01-06

    IPC分类号: C12P2100

    摘要: The present invention provides antagonists to cell adhesion useful in controlling the negative effects of inflammation, and the metastasis of cancer cells. These antagonists are ligands to E-selectin containing the sialyl Lex structure, including sialyl Lex glycoproteins, sialyl Lex glycolipids, and sialyl Lex oligsaccharides, and other related sialyl Lex-containing molecules capable of inhibiting E-selectin mediated cell adhesion to endothelial cells. The present invention also provides antibodies against sialyl Lex determinants capable of interrupting E-selectin mediated cell adhesion, which are also considered antagonists according to the present invention. The present invention also provides methods of using the antagonists of the present invention to reduce inflammation, and methods to inhibit the process of metastasis by carcinogenic cells. The present invention also provides nucleic acid molecules encoding the glycoprotein antagonists of the present invention, in particular soluble chimeric leukosialin, and vectors capable of expressing these nucleic acid molecules, as well as cells capable of producing sialyl Lex positive recombinant glycoproteins. The present invention further provides a method of determining metastatic potential by comparing the efficiency of E-selectin-mediated adhesion of cell samples. In addition the present invention provides a method of producing a preferred antagonist of the present invention, sialyl Lex positive glycoproteins, in particular, sialy Lex positive chimeric leukosialin.

    摘要翻译: 本发明提供了可用于控制炎症的负面作用和癌细胞转移的细胞粘附的拮抗剂。 这些拮抗剂是含有唾液酸Lex结构的E-选择素的配体,包括唾液酸Lex糖蛋白,唾液酸Lex糖脂和唾液酸Lex低聚糖,以及能够抑制E-选择蛋白介导的细胞粘附于内皮细胞的其它相关唾液酸含Lex分子。 本发明还提供能够中断E-选择蛋白介导的细胞粘附的唾液酸基决定簇的抗体,其也被认为是根据本发明的拮抗剂。 本发明还提供了使用本发明的拮抗剂来减少炎症的方法,以及抑制致癌细胞转移过程的方法。 本发明还提供编码本发明的糖蛋白拮抗剂,特别是可溶性嵌合白血球蛋白的核酸分子,以及能够表达这些核酸分子的载体,以及能产生唾液酸Lex阳性重组糖蛋白的细胞。 本发明还提供了通过比较E-选择蛋白介导的细胞样品粘附的效率来确定转移潜能的方法。 此外,本发明提供了制备本发明优选的拮抗剂,唾液酸Lex阳性糖蛋白,特别是唾液酸Lex阳性嵌合白血球蛋白的方法。

    Methods for inhibiting tumor metastasis, and peptides useful therfor
    40.
    发明授权
    Methods for inhibiting tumor metastasis, and peptides useful therfor 有权
    抑制肿瘤转移的方法,以及有用的方法

    公开(公告)号:US06451969B1

    公开(公告)日:2002-09-17

    申请号:US09232484

    申请日:1999-01-15

    IPC分类号: C07K500

    CPC分类号: C07K7/06 A61K38/00

    摘要: In accordance with the present invention, there are provided peptides that bind to a member of the mammalian selectin family and inhibit the binding of a carbohydrate to the selectin. Invention peptides are useful to inhibit of the adhesion of cells containing particular cell-surface carbohydrates to cells containing cell-surface selecting. Also provided are pharmaceutical compositions comprising invention peptides useful in methods for inhibiting a carbohydrate from binding to a selectin, and in methods of inhibiting tumor cell metastasis in a subject.

    摘要翻译: 根据本发明,提供了结合哺乳动物选择蛋白家族成员并抑制碳水化合物与选择蛋白结合的肽。 本发明的肽可用于抑制含有特定细胞表面碳水化合物的细胞对含有细胞表面选择的细胞的粘附。 还提供了包含可用于抑制碳水化合物与选择素结合的方法的发明肽的药物组合物,以及抑制受试者中肿瘤细胞转移的方法。